Related Experiment Videos
In vitro effect of hyperthermia on natural cell-mediated cytotoxicity
M P Fuggetta1, E Alvino, M Tricarico
1Institute of Experimental Medicine, CNR, Rome, Italy.
Anticancer Research
|August 6, 2000
Summary
Hyperthermia (HY) temporarily impairs natural killer (NK) cell activity and their response to interleukin-2 (IL-2) activation. This cancer treatment affects immune cells, not cancer cells, during therapy.
Area of Science:
- Immunology
- Cancer Therapy
- Cellular Biology
Background:
- Hyperthermia (HY), a cancer treatment, is known to suppress natural cell-mediated immunity in vitro.
- Natural killer (NK) cells are crucial components of the innate immune system, responsible for eliminating infected or cancerous cells.
Purpose of the Study:
- To confirm the inhibitory effect of hyperthermia on NK cell activity.
- To evaluate hyperthermia's influence on the generation and cytotoxic function of IL-2-activated NK cells.
- To assess the impact of simultaneous hyperthermia exposure on effector and target cells.
Main Methods:
- NK cell activity was assessed after exposure to hyperthermia (42°C for 1 hour).
- The generation of IL-2-activated NK cells was evaluated after hyperthermia treatment of mononuclear cells.
- Cytotoxic activity of IL-2-activated NK cells was measured after hyperthermia exposure.
- Simultaneous exposure of effector and target cells to hyperthermia during cytotoxicity assays was performed.
Main Results:
- Hyperthermia significantly reduced NK cell lytic activity, an effect that was transient and not due to apoptosis.
- Pre-treatment of mononuclear cells with hyperthermia did not affect the generation of IL-2-activated NK cells.
- Hyperthermic treatment of IL-2-activated NK cells markedly reduced their cytotoxic activity.
- Simultaneous hyperthermia exposure during assays impaired NK and IL-2-activated NK cell lytic activity, specifically affecting effector cells.
- Hyperthermia exposure of target cells alone did not significantly alter their susceptibility to lysis.
Conclusions:
- Hyperthermia profoundly inhibits NK cell cytotoxic function, impacting both resting and IL-2-activated cells.
- The observed impairment is specific to immune effector cells, not target cancer cells.
- Therapeutic hyperthermia may significantly alter immune responses during cancer treatment.